Our prior in vitro and in vivo experiments have provided evidence that the knockdown of FYB1 can impede the proliferation of T-ALL cells, induce apoptosis, and subsequently increase the survival rate of mice. Here, FYB1 is linked to acute lymphoblastic leukemia.